NCT05445856

Brief Summary

A randomized controlled trial evaluating the efficacy and safety of single-shot intraoperative methadone for postoperative pain in patients undergoing tonsillectomy. Fentanyl is used as an active comparator

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
130

participants targeted

Target at P75+ for phase_4 postoperative-pain

Timeline
Completed

Started Nov 2022

Typical duration for phase_4 postoperative-pain

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 30, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 6, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

November 28, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

December 5, 2023

Status Verified

December 1, 2023

Enrollment Period

1.1 years

First QC Date

June 30, 2022

Last Update Submit

December 4, 2023

Conditions

Keywords

Postoperative painMethadone

Outcome Measures

Primary Outcomes (2)

  • Postoperative pain

    Pain at swallowing (numeric rating scale (NRS) 0-10, lower scores are better outcomes)

    On arrival at the post-anesthesia care unit

  • Opioid consumption

    Cumulative postoperative opioid consumption in morphine equivalents

    First 5 postoperative days

Secondary Outcomes (4)

  • Postoperative pain

    1, 2, 3, 5 and 7 days after surgery

  • Opioid consumption

    1 and 7 days after surgery

  • Postoperative nausea and vomiting (none, mild, moderate, severe)

    1, 2 and 3 days after surgery

  • Sedation

    4 hours after surgery

Study Arms (2)

Methadone

EXPERIMENTAL

Single-shot intravenous methadone 0.2 mg/kg administered intraoperatively

Drug: Methadone

Fentanyl

ACTIVE COMPARATOR

Single-shot intravenous fentanyl 3 microgram/kg administered intraoperatively

Drug: Fentanyl

Interventions

Methadone is administered as a single intravenous dose after induction of anesthesia and prior to initiation of surgery

Methadone

Fentanyl is administered as a single intravenous dose after induction of anesthesia and prior to initiation of surgery

Fentanyl

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients (≥18 years) scheduled for elective tonsillectomy

You may not qualify if:

  • American Society of Anaesthesiologists (ASA) physical status IV or V
  • Allergy to study drugs
  • Daily use of opioids 7 days prior to surgery
  • Inability to provide informed consent
  • Severe respiratory insufficiency
  • Heart failure
  • Acute alcohol intoxication/delirium tremens
  • Increased intracranial pressure
  • Acute liver disease
  • Liver insufficiency
  • Kidney insufficiency
  • Treatment with rifampicin
  • Treatment with any drug prolonging the QT-interval
  • Pregnancy (every female not using contraceptives will be screened with urine human choriogonadotropin)
  • Breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anaesthesiology and Intensive Care

Randers, Denmark

RECRUITING

Related Publications (5)

  • Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Shear TD, Deshur MA, Vender JS, Benson J, Newmark RL. Clinical Effectiveness and Safety of Intraoperative Methadone in Patients Undergoing Posterior Spinal Fusion Surgery: A Randomized, Double-blinded, Controlled Trial. Anesthesiology. 2017 May;126(5):822-833. doi: 10.1097/ALN.0000000000001609.

    PMID: 28418966BACKGROUND
  • Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Marymont JH, Shear T, Parikh KN, Patel SS, Gupta DK. Intraoperative Methadone for the Prevention of Postoperative Pain: A Randomized, Double-blinded Clinical Trial in Cardiac Surgical Patients. Anesthesiology. 2015 May;122(5):1112-22. doi: 10.1097/ALN.0000000000000633.

    PMID: 25837528BACKGROUND
  • Gottschalk A, Durieux ME, Nemergut EC. Intraoperative methadone improves postoperative pain control in patients undergoing complex spine surgery. Anesth Analg. 2011 Jan;112(1):218-23. doi: 10.1213/ANE.0b013e3181d8a095. Epub 2010 Apr 24.

    PMID: 20418538BACKGROUND
  • Udelsmann A, Maciel FG, Servian DC, Reis E, de Azevedo TM, Melo Mde S. Methadone and morphine during anesthesia induction for cardiac surgery. Repercussion in postoperative analgesia and prevalence of nausea and vomiting. Rev Bras Anestesiol. 2011 Nov-Dec;61(6):695-701. doi: 10.1016/S0034-7094(11)70078-2. English, Multiple languages.

    PMID: 22063370BACKGROUND
  • Bondergaard M, Uhrbrand PG, Karaca T, Rhode M, Kjaergaard T, Svendsen RT, Klug TE, Nikolajsen L, Friesgaard KD. Intraoperative methadone for postoperative pain in adult patients undergoing tonsillectomy-a randomised controlled trial. BJA Open. 2025 May 26;14:100418. doi: 10.1016/j.bjao.2025.100418. eCollection 2025 Jun.

MeSH Terms

Conditions

Pain, Postoperative

Interventions

MethadoneFentanyl

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

KetonesOrganic ChemicalsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Lone Nikolajsen, PhD, DMSc

    Aarhus University Hospital, Department of Anesthesia and Intensive Care

    STUDY CHAIR

Central Study Contacts

Michael Bøndergaard, MD

CONTACT

Kristian Friesgaard, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 30, 2022

First Posted

July 6, 2022

Study Start

November 28, 2022

Primary Completion

January 1, 2024

Study Completion

August 1, 2024

Last Updated

December 5, 2023

Record last verified: 2023-12

Locations